Open Beta
TREN
MetriLume
TREN

US marketsBTCY

SEC-sourced researchBeta

BTCY

BIOTRICITY INC.

Company comparison ↗

Data passport

CIK
0001630113
Exchange
OTC
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Sep 28, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: March 2024: 12,063,345.0000 USD; March 2025: 13,790,294.0000 USD13.8M USD0 USD0March 2024March 2025
BTCY · Exact amounts and source periods · USD
Period endRevenueFiling date
March 202412,063,345.0000Jul 18, 2025
March 202513,790,294.0000Jul 18, 2025

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
March 202513,790,294.0000-8,421,179.0000-2,380,177.00005,640,954.000035,655,054.0000Jul 18, 2025
March 202412,063,345.0000-14,094,283.0000-6,693,912.00005,942,625.000035,919,442.0000Jul 18, 2025

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$13.79MMarch 2025Jul 18, 202510-K/A
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$12.06MMarch 2024Jul 18, 202510-K/A
Net incomeNetIncomeLoss-$8.42MMarch 2025Jul 18, 202510-K/A
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$2.38MMarch 2025Jul 18, 202510-K/A
Total assetsAssets$5.64MMarch 2025Jul 18, 202510-K/A
Total liabilitiesLiabilities$35.66MMarch 2025Jul 18, 202510-K/A

New filings

Explore methodology ↗